EYPT FY 2020 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+69.1% YoY

Gross Profit

$29M83.1% margin

Operating Income

-$37M-108.3% margin

Net Income

-$45M-131.8% margin

EPS (Diluted)

$-3.54

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$92M

Total Liabilities

$73M

Stockholders' Equity

$19M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$20M	+69.1%
Gross Profit	$29M	$18M	+61.9%
Operating Income	-$37M	-$48M	+22.1%
Net Income	-$45M	-$57M	+20.1%